| ABB Ltd | Shareholding | 3 Oct 2025 | Active | digital technologies |
| Asset Match | Shareholding | 18 Mar 2024 | Active | private market trading platform |
| Avenue Therapeutics | Shareholding | 18 Mar 2024 | Active | research and development in neurological diseases |
| Banco Santander | Shareholding | 3 Oct 2025 | Active | – |
| Brewdog | Shareholding | 18 Mar 2024 | Active | brewing |
| Candel Therapeutics | Shareholding | 18 Mar 2024 | Active | research and development in viral immunotherapies |
| CMT MTN PTE Ltd | Shareholding | 3 Oct 2025 | Active | financial services |
| CQS Credit Multi Asset Fund | Shareholding | 18 Mar 2024 | Active | research-driven credit strategies hedge fund |
| Cyngn Inc | Shareholding | 7 Feb 2025 | Active | autonomous vehicle technology for industrial fleets |
| Deepbridge Life Sciences | Shareholding | 18 Mar 2024 | Active | investment in healthcare innovation companies |
| East Rocky LLP | Shareholding | 18 Mar 2024 | Active | hedge fund |
| FibaTech Industries | Shareholding | 18 Mar 2024 | Active | production of fibre-reinforced polymers |
| Fortress Biotech | Shareholding | 18 Mar 2024 | Active | research and development in biopharmaceuticals |
| Guinness Ventures | Shareholding | 18 Mar 2024 | Active | investment in early-stage businesses |
| HzO | Shareholding | 18 Mar 2024 | Active | nanocoating solutions for electronics |
| Itemize Corp | Shareholding | 18 Mar 2024 | Active | financial transaction processing |
| Libero Pharma | Shareholding | 18 Mar 2024 | Active | research and commercial development in opioid receptor antagonism |
| Linde plc | Shareholding | 3 Oct 2025 | Active | chemicals and gas |
| Map of Agriculture | Shareholding | 18 Mar 2024 | Active | global data platform connecting farms and industry |
| Money Hub | Shareholding | 18 Mar 2024 | Active | financial services app |
| Mustang Bio | Shareholding | 18 Mar 2024 | Active | research and development in next generation therapies |
| Optus Finance Pty | Shareholding | 3 Oct 2025 | Active | – |
| Plaquetec Limited | Shareholding | 18 Mar 2024 | Active | research and commercial development concerning coronary heart disease |
| Ptarmigan Planning Ltd | Shareholding | 18 Mar 2024 | Active | strategic land planning |
| Roche Kapitalmarkt | Shareholding | 3 Oct 2025 | Active | – |
| SAB Biotherapeutics | Shareholding | 7 Nov 2024 | Active | biotechnology |
| Sabby Volatility Fund | Shareholding | 18 Mar 2024 | Active | hedge fund |
| Singapore Life Holdings | Shareholding | 3 Oct 2025 | Active | – |
| Single Pass | Shareholding | 9 Jun 2025 | Active | electrocautery device producer |
| Six Group AG | Shareholding | 3 Oct 2025 | Active | financial market infrastructure |
| Sonorous NV | Shareholding | 18 Mar 2024 | Active | research and commercial development in symptomatic cerebral venous diseases |
| Swiss Re Subordinated Finance | Shareholding | 3 Oct 2025 | Active | – |
| Terrestrial Energy | Shareholding | 18 Mar 2024 | Active | molten salt and fission technology |
| Thermo Fisher Scientific Inc | Shareholding | 3 Oct 2025 | Active | – |
| Toronto Dominion Bank | Shareholding | 3 Oct 2025 | Active | – |
| Valorum Biologics | Shareholding | 15 May 2025 | Active | pharmaceuticals |
| Vos Amis Limited | Shareholding | 18 Mar 2024 | Active | investment advice, personal services and real estate |
| WebTel Mobi | Shareholding | 18 Mar 2024 | Active | specialised network provider |
| TG Therapeutics | Shareholding | 18 Mar 2024 | Ceased 12 Nov 2025 | research and development in B-cell biologies |
